Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

4 of 8 completed trials have results

Key Signals

2 recruiting4 with results

Enrollment Performance

Analytics

N/A
9(100.0%)
9Total
N/A(9)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)